S. Fracchioli
- Genetics top 1%
- Molecular Biology top 10%
- Oncology top 5%
- Hematology top 2%
- Cancer Research top 5%
- Co-authors
- Dionyssios KatsarosEleftherios P. DiamandisAndreas ScorilasGeorge M. YousefM MassobrioIrene A. Rigault de la LongraisAntoninus SoosaipillaiNuo Yang
- Topics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers)Ovarian cancer diagnosis and treatment (8 papers)Cancer, Hypoxia, and Metabolism (5 papers)
- Partner nations
- ItalyCanadaUnited States
In The Last Decade
S. Fracchioli
34 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 87
- Genetics 985
- Molecular Biology 938
- Oncology 661
- Hematology 470
- Cancer Research 424
Countries citing papers authored by S. Fracchioli
This map shows the geographic impact of S. Fracchioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Fracchioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Fracchioli more than expected).
Fields of papers citing papers by S. Fracchioli
This network shows the impact of papers produced by S. Fracchioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Fracchioli. The network helps show where S. Fracchioli may publish in the future.
Co-authorship network of co-authors of S. Fracchioli
This figure shows the co-authorship network connecting the top 25 collaborators of S. Fracchioli. A scholar is included among the top collaborators of S. Fracchioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Fracchioli. S. Fracchioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 57 | |
| 2 | 33 | |
| 3 | 20 | |
| 4 | 73 | |
| 5 | Methylation of the IGFBP-3 gene and prognosis of epithelial ovarian cancer | 1 |
| 6 | 52 | |
| 7 | 57 | |
| 8 | 7 | |
| 9 | 167 | |
| 10 | 57 | |
| 11 | 54 | |
| 12 | Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. | 52 |
| 13 | The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. | 131 |
| 14 | Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. | 224 |
| 15 | Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. | 99 |
| 16 | 64 | |
| 17 | 38 | |
| 18 | 122 | |
| 19 | Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. | 108 |
| 20 | [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. | 1 |
About S. Fracchioli
S. Fracchioli is a scholar working on Genetics, Reproductive Medicine and Immunology and Allergy, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Ovarian cancer diagnosis and treatment (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Genetics (985 citations), Hematology (470 citations) and Reproductive Medicine (315 citations). S. Fracchioli has collaborated with scholars based in Italy, Canada and United States. Frequent co-authors include Dionyssios Katsaros, Eleftherios P. Diamandis, Andreas Scorilas, George M. Yousef, M Massobrio, Irene A. Rigault de la Longrais, Antoninus Soosaipillai, Nuo Yang, George Coukos and D Katsaros. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.